I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Combined treatment by burosumab and a calcimimetic can amel..:
Yuichi Takashi
;
Kyoko Toyokawa
;
Naoki Oda
...
https://www.frontiersin.org/articles/10.3389/fendo.2022.1004624/full. , 2022
Link:
https://doi.org/10.3389/fendo.2022.1004624
RT Journal T1
Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:ab92c8ce2f354df88e32ba7ea54d1bbf&Exemplar=1&LAN=DE A1 Yuichi Takashi A1 Kyoko Toyokawa A1 Naoki Oda A1 Yoshimi Muta A1 Hisashi Yokomizo A1 Seiji Fukumoto A1 Daiji Kawanami PB Frontiers Media S.A. YR 2022 K1 X-linked hypophosphatemia K1 tertiary hyperparathyroidism K1 fibroblast growth factor 23 K1 parathyroid hormone K1 burosumab K1 evocalcet K1 Diseases of the endocrine glands. Clinical endocrinology K1 RC648-665 JF https://www.frontiersin.org/articles/10.3389/fendo.2022.1004624/full LK http://dx.doi.org/https://doi.org/10.3389/fendo.2022.1004624 DO https://doi.org/10.3389/fendo.2022.1004624 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)